Traumacel FAM Trium in the Post-market Surveillance Phase

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

January 2, 2021

Study Completion Date

January 2, 2021

Conditions

BleedingSurgical Wound

Interventions

DEVICE

Traumacel FAM Trium

Absorbable Hemostat (oxidized non-regenerated cellulose)

DEVICE

Surgicel Fibrillar

Absorbable Hemostat (oxidized regenerated cellulose)

Trial Locations (1)

University Hospital Hradec Králové, Hradec Králové

All Listed Sponsors

lead

Bioster, a.s.

INDUSTRY

NCT05177874 - Traumacel FAM Trium in the Post-market Surveillance Phase | Biotech Hunter | Biotech Hunter